Research Roundup

Debbie Rigby rounds up the latest in research news Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β2-Agonist in Patients with Chronic Obstructive Pulmonary Disease Among patients with COPD without exacerbations in the previous year, adherence to once daily dual bronchodilator therapy (umeclidinium/vilanterol) was superior to twice daily ICS/LABA at 12 months. The finding was consistent